The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research
- 1 December 2003
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 30 (6) , 749-762
- https://doi.org/10.1053/j.seminoncol.2003.09.008
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialThe Lancet, 2003
- The relationship of APOE genotype to neuropsychological performance in long‐term cancer survivors treated with standard dose chemotherapyPsycho‐Oncology, 2003
- Decision-making in early breast cancer: guidelines and decision toolsEuropean Journal Of Cancer, 2002
- Hormone replacement therapy for cognitive function in postmenopausal womenPublished by Wiley ,2002
- Preconditioning-mediated neuroprotection through erythropoietin?The Lancet, 2002
- Cognitive Function and Reproductive Hormones in Adjuvant Therapy for Breast CancerJournal of Pain and Symptom Management, 2001
- Cognitive Function in Postmenopausal Women Treated with RaloxifeneNew England Journal of Medicine, 2001
- Aromatase in Aging WomenSeminars in Reproductive Medicine, 1999
- Screening for anxiety and depression in cancer patients: the effects of disease and treatmentEuropean Journal Of Cancer, 1994
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993